{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:14:41Z","timestamp":1790673281698,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.imlet.2017.09.001","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T13:32:07Z","timestamp":1504704727000},"page":"2-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Toll Like Receptors in systemic sclerosis: An emerging target"],"prefix":"10.1016","volume":"195","author":[{"given":"Steven","family":"O\u2019Reilly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.imlet.2017.09.001_bib0005","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.imlet.2017.09.001_bib0010","doi-asserted-by":"crossref","first-page":"R128","DOI":"10.1186\/ar3066","article-title":"Characterization of monocyte\/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis","volume":"12","author":"Higashi-Kuwata","year":"2010","journal-title":"Arthritis. Res. Ther."},{"issue":"9","key":"10.1016\/j.imlet.2017.09.001_bib0015","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/rheumatology\/kes090","article-title":"T cells in systemic sclerosis: a reappraisal","volume":"51","author":"O\u2019Reilly","year":"2012","journal-title":"Rheumatology"},{"issue":"24","key":"10.1016\/j.imlet.2017.09.001_bib0020","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"van Laar","year":"2014","journal-title":"JAMA"},{"issue":"9790","key":"10.1016\/j.imlet.2017.09.001_bib0025","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","article-title":"Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial","volume":"378","author":"Burt","year":"2011","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.imlet.2017.09.001_bib0030","first-page":"451","article-title":"Analysis of anti\u2013topoisomerase I antibodies in patients with systemic sclerosis before and after autologous stem cell transplantation","volume":"56","author":"Henes","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.imlet.2017.09.001_bib0035","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2013.10","article-title":"Role of toll-like receptors in systemic sclerosis","volume":"15","author":"Ciechomska","year":"2013","journal-title":"Expert Rev. Mol. Med."},{"issue":"6640","key":"10.1016\/j.imlet.2017.09.001_bib0040","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/41131","article-title":"A human homologue of the Drosophila Toll protein signals activation of adaptive immunity","volume":"388","author":"Medzhitov","year":"1997","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.imlet.2017.09.001_bib0045","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2017.09.001_bib0050","first-page":"11","article-title":"Epigenetic modulation as a therapeutic prospect for treatment of autoimmune rheumatic diseases","author":"Ciechomska","year":"2016","journal-title":"Mediators Inflamm."},{"issue":"5","key":"10.1016\/j.imlet.2017.09.001_bib0055","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1073\/pnas.0610731104","article-title":"MicroRNA-155 is induced during the macrophage inflammatory response","volume":"104","author":"O'Connell","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.imlet.2017.09.001_bib0060","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1074-7613(02)00446-6","article-title":"SOCS1\/JAB is a negative regulator of LPS-Induced macrophage activation","volume":"17","author":"Kinjyo","year":"2002","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.imlet.2017.09.001_bib0065","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.immuni.2009.06.024","article-title":"The kinase akt1 controls macrophage response to lipopolysaccharide by regulating MicroRNAs","volume":"31","author":"Androulidaki","year":"2009","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.imlet.2017.09.001_bib0070","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","article-title":"Tolerance, danger, and the extended family","volume":"12","author":"Matzinger","year":"1994","journal-title":"Annu. Rev. Immunol."},{"issue":"6894","key":"10.1016\/j.imlet.2017.09.001_bib0075","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature00858","article-title":"Release of chromatin protein HMGB1 by necrotic cells triggers inflammation","volume":"418","author":"Scaffidi","year":"2002","journal-title":"Nature"},{"issue":"7285","key":"10.1016\/j.imlet.2017.09.001_bib0080","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature08780","article-title":"Circulating mitochondrial DAMPs cause inflammatory responses to injury","volume":"464","author":"Zhang","year":"2010","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.imlet.2017.09.001_bib0085","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00281-015-0503-7","article-title":"Role of innate immune system in systemic sclerosis","volume":"37","author":"Fullard","year":"2015","journal-title":"Semin. Immunopathol."},{"issue":"22","key":"10.1016\/j.imlet.2017.09.001_bib0090","doi-asserted-by":"crossref","first-page":"16336","DOI":"10.1074\/jbc.M608467200","article-title":"Post-translational methylation of high mobility group box 1 box 1 (HMGB1) causes its cytoplasmic localization in neutrophils","volume":"282","author":"Ito","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.imlet.2017.09.001_bib0095","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaut.2007.02.005","article-title":"Clearance deficiency and systemic lupus erythematosus (SLE)","volume":"28","author":"Gaipl","year":"2007","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.imlet.2017.09.001_bib0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/ard.2005.035733","article-title":"Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement","volume":"65","author":"Bijl","year":"2006","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.imlet.2017.09.001_bib0105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4049\/jimmunol.181.1.22","article-title":"Cutting edge: TLR2 is a functional receptor for acute-Phase serum amyloid a","volume":"181","author":"Cheng","year":"2008","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2017.09.001_bib0110","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1189\/jlb.0607-408","article-title":"Serum amyloid A mediates human neutrophil production of reactive oxygen species through a receptor independent of formyl peptide receptor like-1","volume":"83","author":"Bj\u00f6rkman","year":"2008","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.imlet.2017.09.001_bib0115","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.imlet.2017.09.001_bib0120","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00062752-200001000-00012","article-title":"Expression and function of serum amyloid A: a major acute-phase protein, in normal and disease states","volume":"7","author":"Urieli-Shoval","year":"2000","journal-title":"Curr. Opin. Hematol."},{"issue":"1","key":"10.1016\/j.imlet.2017.09.001_bib0125","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1186\/ar3221","article-title":"Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblasts","volume":"13","author":"Agarwal","year":"2011","journal-title":"Arthritis. Res. Ther."},{"issue":"3","key":"10.1016\/j.imlet.2017.09.001_bib0130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/imm.12260","article-title":"Serum amyloid A induces interleukin-6 in dermal fibroblasts via Toll-like receptor 2: interleukin-1 receptor-associated kinase 4 and nuclear factor-\u03baB","volume":"143","author":"O'Reilly","year":"2014","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.imlet.2017.09.001_bib0135","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cytogfr.2012.04.003","article-title":"Interleukin-6: its role in fibrosing conditions","volume":"23","author":"O\u2019Reilly","year":"2012","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.imlet.2017.09.001_bib0140","doi-asserted-by":"crossref","first-page":"e0110820","DOI":"10.1371\/journal.pone.0110820","article-title":"Serum amyloid a is a marker for pulmonary involvement in systemic sclerosis","volume":"10","author":"Lakota","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.imlet.2017.09.001_bib0145","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.4049\/jimmunol.172.2.1256","article-title":"Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by toll-Like receptor 2 ligands","volume":"172","author":"Pierer","year":"2004","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.imlet.2017.09.001_bib0150","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1002\/art.34490","article-title":"Brief Report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity","volume":"64","author":"Koumakis","year":"2012","journal-title":"Arthritis Rheumatism"},{"issue":"1","key":"10.1016\/j.imlet.2017.09.001_bib0155","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-016-1023-5","article-title":"Salivary psoriasin (S100A7) correlates with diffusion capacity of carbon monoxide in a large cohort of systemic sclerosis patients","volume":"14","author":"Giusti","year":"2016","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.imlet.2017.09.001_bib0160","doi-asserted-by":"crossref","first-page":"692","DOI":"10.4049\/jimmunol.182.1.692","article-title":"Targeting TLR2 attenuates pulmonary inflammation and fibrosis by reversion of suppressive immune microenvironment","volume":"182","author":"Yang","year":"2009","journal-title":"J. Immunol."},{"issue":"14","key":"10.1016\/j.imlet.2017.09.001_bib0165","doi-asserted-by":"crossref","first-page":"9952","DOI":"10.1074\/jbc.M113.545822","article-title":"Interleukin-6 (IL-6) trans signaling drives a STAT3-dependent pathway that leads to hyperactive transforming growth factor-\u03b2 (TGF-\u03b2) signaling promoting SMAD3 activation and fibrosis via gremlin protein","volume":"289","author":"O'Reilly","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.imlet.2017.09.001_bib0170","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/exd.12673","article-title":"Current frontiers in systemic sclerosis pathogenesis","volume":"24","author":"Ciechomska","year":"2015","journal-title":"Exp. Dermatol."},{"issue":"6","key":"10.1016\/j.imlet.2017.09.001_bib0175","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2353\/ajpath.2008.071049","article-title":"CD19 regulates skin and lung fibrosis via toll-Like receptor signaling in a model of bleomycin-Induced scleroderma","volume":"172","author":"Yoshizaki","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"12","key":"10.1016\/j.imlet.2017.09.001_bib0180","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nri2873","article-title":"Sterile inflammation: sensing and reacting to damage","volume":"10","author":"Chen","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2017.09.001_bib0185","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/CS20140467","article-title":"Pound the alarm: danger signals in rheumatic diseases","volume":"128","author":"O\u2019Reilly","year":"2015","journal-title":"Clin. Sci."},{"issue":"4","key":"10.1016\/j.imlet.2017.09.001_bib0190","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1594","article-title":"High-mobility group Box 1 Box 1 protein (HMGB1): nuclear weapon in the immune arsenal","volume":"5","author":"Lotze","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.imlet.2017.09.001_bib0195","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1074\/jbc.M306793200","article-title":"Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 box 1 protein","volume":"279","author":"Park","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.imlet.2017.09.001_bib0200","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1315","article-title":"Regulation of lung injury and repair by Toll-like receptors and hyaluronan","volume":"11","author":"Jiang","year":"2005","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.imlet.2017.09.001_bib0205","doi-asserted-by":"crossref","first-page":"E1880","DOI":"10.1210\/jc.2012-1670","article-title":"Increased tenascin C and toll-Like receptor 4 levels in visceral adipose tissue as a link between inflammation and extracellular matrix remodeling in obesity","volume":"97","author":"Catal\u00e1n","year":"2012","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"7","key":"10.1016\/j.imlet.2017.09.001_bib0210","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nm.1987","article-title":"Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease","volume":"15","author":"Midwood","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.imlet.2017.09.001_bib0215","doi-asserted-by":"crossref","first-page":"11703","DOI":"10.1038\/ncomms11703","article-title":"Tenascin-C drives persistence of organ fibrosis","volume":"7","author":"Bhattacharyya","year":"2016","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.imlet.2017.09.001_bib0220","doi-asserted-by":"crossref","first-page":"10229","DOI":"10.1074\/jbc.M100099200","article-title":"The extra domain a of fibronectin activates toll-like receptor 4","volume":"276","author":"Okamura","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.imlet.2017.09.001_bib0225","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/path.3010","article-title":"Recipient-derived EDA fibronectin promotes cardiac allograft fibrosis","volume":"226","author":"Booth","year":"2012","journal-title":"J. Pathol."},{"issue":"232","key":"10.1016\/j.imlet.2017.09.001_bib0230","doi-asserted-by":"crossref","first-page":"232ra50","DOI":"10.1126\/scitranslmed.3008264","article-title":"FibronectinEDA promotes chronic cutaneous fibrosis through toll-Like receptor signaling","volume":"6","author":"Bhattacharyya","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.imlet.2017.09.001_bib0235","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajpath.2012.09.007","article-title":"Toll-Like receptor 4 signaling augments transforming growth factor-(responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma","volume":"182","author":"Bhattacharyya","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.imlet.2017.09.001_bib0240","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/art.38901","article-title":"Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis","volume":"67","author":"Takahashi","year":"2015","journal-title":"Arthritis Rheumatology"},{"issue":"4","key":"10.1016\/j.imlet.2017.09.001_bib0245","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/03009740802572467","article-title":"Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion","volume":"38","author":"van Lieshout","year":"2009","journal-title":"Scand. J. Rheumatol."},{"issue":"2","key":"10.1016\/j.imlet.2017.09.001_bib0250","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10067-010-1610-4","article-title":"Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis","volume":"30","author":"Hasegawa","year":"2011","journal-title":"Clin. Rheumatol."},{"issue":"5663","key":"10.1016\/j.imlet.2017.09.001_bib0255","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1126\/science.1093620","article-title":"Species-Specific recognition of single-Stranded RNA via toll-like receptor 7 and 8","volume":"303","author":"Heil","year":"2004","journal-title":"Science"},{"issue":"7184","key":"10.1016\/j.imlet.2017.09.001_bib0260","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nature06726","article-title":"UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes","volume":"452","author":"Kim","year":"2008","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.imlet.2017.09.001_bib0265","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.immuni.2011.05.010","article-title":"Unc93B1 restricts systemic lethal inflammation by orchestrating toll-like receptor 7 and 9 trafficking","volume":"35","author":"Fukui","year":"2011","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.imlet.2017.09.001_bib0270","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1038\/jid.2010.200","article-title":"Poly(I:C) drives type I IFN- and TGF[beta]-Mediated inflammation and dermal fibrosis simulating altered gene expression in systemic sclerosis","volume":"130","author":"Farina","year":"2010","journal-title":"J. Invest. Dermatol."},{"issue":"12","key":"10.1016\/j.imlet.2017.09.001_bib0275","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1164\/rccm.201304-0760OC","article-title":"The toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis","volume":"188","author":"O\u2019Dwyer","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"8","key":"10.1016\/j.imlet.2017.09.001_bib0280","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/annrheumdis-2012-201958","article-title":"Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors","volume":"72","author":"Ciechomska","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.imlet.2017.09.001_bib0285","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1084\/jem.20051696","article-title":"Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8","volume":"202","author":"Vollmer","year":"2005","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.imlet.2017.09.001_bib0290","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/art.39602","article-title":"Histone demethylation and toll-like receptor 8?Dependent cross-Talk in monocytes promotes transdifferentiation of fibroblasts in systemic sclerosis via fra-2","volume":"68","author":"Ciechomska","year":"2016","journal-title":"Arthritis Rheumatology"},{"issue":"2","key":"10.1016\/j.imlet.2017.09.001_bib0295","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/imm.12200","article-title":"Epstein\u2013Barr virus antibodies mark systemic lupus erythematosus and scleroderma patients negative for anti-DNA","volume":"141","author":"Fattal","year":"2014","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.imlet.2017.09.001_bib0300","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000086585","article-title":"Angioimmunoblastic t cell lymphoma with an unusual proliferation of epstein-Barr virus-Associated large B cells arising in a patient with progressive systemic sclerosis","volume":"114","author":"Yamamoto","year":"2005","journal-title":"Acta Haematol."},{"issue":"4","key":"10.1016\/j.imlet.2017.09.001_bib0305","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/jid.2013.423","article-title":"Epstein-Barr virus infection induces aberrant TLR activation pathway and fibroblast-Myofibroblast conversion in scleroderma","volume":"134","author":"Farina","year":"2014","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.imlet.2017.09.001_bib0310","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4049\/jimmunol.1103099","article-title":"Gadolinium compounds signaling through TLR 4 and TLR 7 in normal human macrophages: establishment of a proinflammatory phenotype and implications for the pathogenesis of nephrogenic systemic fibrosis","volume":"189","author":"Wermuth","year":"2012","journal-title":"J. Immunol."},{"issue":"45","key":"10.1016\/j.imlet.2017.09.001_bib0315","doi-asserted-by":"crossref","first-page":"19432","DOI":"10.1073\/pnas.1010603107","article-title":"Cytokine-dependent but acquired immunity-independent arthritis caused by DNA escaped from degradation","volume":"107","author":"Kawane","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"57","key":"10.1016\/j.imlet.2017.09.001_bib0320","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001510","article-title":"TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis","volume":"2","author":"Trujillo","year":"2010","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.imlet.2017.09.001_bib0325","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ajpath.2014.12.011","article-title":"Sustained activation of toll-Like receptor 9 induces an invasive phenotype in lung fibroblasts","volume":"185","author":"Kirillov","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.imlet.2017.09.001_bib0330","doi-asserted-by":"crossref","first-page":"420e","DOI":"10.1097\/PRS.0000000000000471","article-title":"The nucleic acid scavenger polyamidoamine third-Generation dendrimer inhibits fibroblast activation and granulation tissue contraction","volume":"134","author":"Holl","year":"2014","journal-title":"Plast. Reconstr. Surg."},{"issue":"12","key":"10.1016\/j.imlet.2017.09.001_bib0335","doi-asserted-by":"crossref","first-page":"e82571","DOI":"10.1371\/journal.pone.0082571","article-title":"Natural killer cell-Dependent anti-Fibrotic pathway in liver injury via toll-Like receptor-9","volume":"8","author":"Abu-Tair","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.imlet.2017.09.001_bib0340","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCINTERVENTIONS.111.967596","article-title":"Treatment with OPN-305, a humanized anti?Toll-Like receptor-2 antibody, reduces myocardial Ischemia\/Reperfusion injury in pigs. circulation","volume":"5","author":"Arslan","year":"2012","journal-title":"Cardiovasc. Intervent."},{"issue":"4","key":"10.1016\/j.imlet.2017.09.001_bib0345","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.bbalip.2014.01.008","article-title":"TLR2\/1 and sphingosine 1-phosphate modulate inflammation: myofibroblast differentiation and cell migration in fibroblasts","volume":"1841","author":"Hamidi","year":"2014","journal-title":"Biochim. et Biophys. Acta (BBA) \u2212 Mol. Cell Biol. Lipids"},{"issue":"2","key":"10.1016\/j.imlet.2017.09.001_bib0350","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2353\/ajpath.2007.060657","article-title":"The toll-Like receptor adaptor proteins MyD88 and Mal\/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis","volume":"170","author":"Sacre","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.imlet.2017.09.001_bib0355","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1172\/JCI87532","article-title":"Pericyte MyD88 and IRAK4 control inflammatory and fibrotic responses to tissue injury","volume":"127","author":"Leaf","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2017.09.001_bib0360","article-title":"Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations: a randomized controlled study","author":"Silkoff","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2017.09.001_bib0365","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13075-016-0929-x","article-title":"MicroRNAs in fibrosis: opportunities and challenges","volume":"18","author":"O\u2019Reilly","year":"2016","journal-title":"Arthritis. Res. Ther."},{"issue":"12","key":"10.1016\/j.imlet.2017.09.001_bib0370","doi-asserted-by":"crossref","first-page":"e115596","DOI":"10.1371\/journal.pone.0115596","article-title":"MiR-29a reduces TIMP-1 production by dermal fibroblasts via targeting TGF-(activated kinase 1 binding protein 1, implications for systemic sclerosis","volume":"9","author":"Ciechomska","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.imlet.2017.09.001_bib0375","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1046\/j.1365-2958.2002.02839.x","article-title":"Identification of genes that are associated with DNA repeats in prokaryotes","volume":"43","author":"Jansen","year":"2002","journal-title":"Mol. Microbiol."},{"issue":"5819","key":"10.1016\/j.imlet.2017.09.001_bib0380","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.1138140","article-title":"CRISPR provides acquired resistance against viruses in prokaryotes","volume":"315","author":"Barrangou","year":"2007","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.imlet.2017.09.001_bib0385","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nbt.2661","article-title":"Heritable gene targeting in the mouse and rat using a CRISPR-Cas system","volume":"31","author":"Li","year":"2013","journal-title":"Nat Biotech"},{"key":"10.1016\/j.imlet.2017.09.001_bib0390","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1038\/ncomms4979","article-title":"Long non-coding RNAs and enhancer RNAs regulate the lipopolysaccharide-induced inflammatory response in human monocytes","author":"Ilott","year":"2014","journal-title":"Nat. Commun."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817302845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817302845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T00:28:11Z","timestamp":1547684891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247817302845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":78,"alternative-id":["S0165247817302845"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2017.09.001","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toll Like Receptors in systemic sclerosis: An emerging target","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2017.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}